Genzyme Corporation / SangStat Medical Corporation
2003 · Acquisition/Merger · $600M · Complete
Announcement Sentiment
64
Positive
Announced August 3-4, 2003 at $22.50/share all cash. Acquired Thymoglobulin (US SOT acute therapy leader). Closed September 2003. Sources: Bloomberg 8/3/2003, C&EN, SEC SC TO.